Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-08T07:44:22.516Z Has data issue: false hasContentIssue false
  • English
  • Français

β-Casomorphin immunoreactive materials in cows' milk incubated with various bacterial species

Published online by Cambridge University Press:  01 June 2009

Ulrike Hamel ,
Gerhard Kielwein  and
Hansjörg Teschemacher
Ulrike Hamel
Affiliation:
Rudolf Buchheim-Institut for Pharmacology
Gerhard Kielwein
Affiliation:
Professor of Milk ·Hygiene and Technology, Justus Liebig-Universität Giessen, D-6300 Giessen, FRG
Hansjörg Teschemacher
Affiliation:
Rudolf Buchheim-Institut for Pharmacology
Get access Rights & Permissions [Opens in a new window]

Summary

To obtain information about the possible release of β-casomorphins from β-casein under in vitro conditions, cows' milk was incubated with 13 strains of Gram-negative or Gram-positive bacterial species isolated from bovine milk. After incubation periods of 1–24 d, milk samples were assayed for β-casomorphin-4, -5, -6 or -7 immunoreactive materials. In general, no β-casomorphin immunoreactive material was found in samples incubated with non-caseolytic strains, e.g. Pseudomonas putida or Streptococcus faecalis subsp. faecalis; however, high levels were found in several samples incubated with caseolytic strains, e.g. Ps. aeruginosa or Bacillus cereus. When such materials were present, the amounts of β-casomorphin-4, -6 or -7 greatly exceeded β-casomorphin-5 immunoreactivity. It was concluded that while some of these materials probably represented authentic β-casomorphins, others were more likely to be β-casomorphin precursors.

Type
Original Articles
Information
Journal of Dairy Research , Volume 52 , Issue 1 , February 1985 , pp. 139 - 148
Copyright
Copyright © Proprietors of Journal of Dairy Research 1985

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Brantl, V. & Teschemacher, H. 1983 Opioids in milk. Trends in Pharmacological Sciences 4 193Google Scholar
Brantl, V., Teschemacher, H., Bläsio, J., Henschen, A. & Lottspeich, F. 1981 Opioid activities of β-casomorphins. Life Sciences 28 1903–1909CrossRefGoogle ScholarPubMed
Brantl, V., Teschemacher, H., Henschen, A. & Lottspeich, F. 1979 Novel opioid peptides derived from casein (β-casomorphins). I. Isolation from bovine casein peptone. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 360 1211–1216CrossRefGoogle ScholarPubMed
Chang, K. J., Cuatrecasas, P., Wei, E. T. & Chang, J. K. 1982 Analgesic activity of intracerebroventricular administration of morphiceptin and β-casomorphins: correlation with the morphine (μ) receptor binding affinity. Life Sciences 30 1547–1551CrossRefGoogle Scholar
Chard, T. 1982 An introduction to radioimmunoassay and related techniques, 2nd edn. Amsterdam: ElsevierGoogle Scholar
Gardner, P., Griffin, W. B., Swartz, M. N. & Kunz, L. J. 1970 Nonfermentative gram-negative bacilli of nosocomial interest. American Journal of Medicine 48 735–749CrossRefGoogle ScholarPubMed
Gilardi, G. L. 1972 Infrequently encountered Pseudomonas species causing infection in humans. Annals of Internal Medicine 77 211–215CrossRefGoogle ScholarPubMed
Grecksch, G., Schweicert, C. & Matthies, H. 1981 Evidence for analgesic activity of β-casomorphin in rats. Neuroscience Letters 27 325–328CrossRefGoogle ScholarPubMed
Hartrodt, B., Neubert, K., Fischer, G., Schulz, H. & Barth, A. 1982 [Synthesís and enzymic breakdown of β-casomorphin-5.] Pharmazie 37, 165–169Google ScholarPubMed
Henschen, A., Lottspeich, F., Brantl, V. & Teschemacher, H. 1979 Novel opioid peptides derived from casein (β-casomorphins). II. Structure of active components from bovine casein peptone. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 360 1217–1224Google ScholarPubMed
Kielwein, G. 1976 [Textbook of Dairy Science and Dairy Hygiene.] Berlin: Verlag Paul PareyGoogle Scholar
Krbil, G., Umbach, M., Brantl, V. & Teschemacher, H. 1983 Studies on the enzymatic degradation of β-casomorphins. Life Sciences 33 Supplement I 137–140Google Scholar
Kurup, V. P. & Babcook, J. B. 1979 Use of casein, tyrosine, and hypoxanthine in the identification of nonfermentative gram-negative bacilli. Medical Microbiology and Immunology 167 71–75CrossRefGoogle ScholarPubMed
Lottspeich, F., Henschen, A., Brantl, V. & Teschemacher, H. 1980 Novel opioid peptides derived from casein (β-casomorphins). III. Synthetic peptides corresponding to components from bovine casein peptone. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 361 1835–1839CrossRefGoogle ScholarPubMed
Morley, J. E. 1982 Food peptides: a new class of hormones? Journal of the American Medical Association 247 2379–2380CrossRefGoogle ScholarPubMed
Pedersen, M. M., Marse, E. & Pickett, M. J. 1970 Nonfermentative bacilli associated with man. III. Pathogenicity and antibiotic susceptibility. American Journal of Clinical Pathology 54 178–191CrossRefGoogle Scholar
Schusdziarra, V., Holland, A., Schick, R., De La Fuente, A., Klier, M., Maier, V., Brantl, V. & Pfeiffer, E. F. 1983 a Modulation of post-prandial insulin release by ingested opiate-like substances in dogs. Diabetologia 24 113–116CrossRefGoogle ScholarPubMed
Schusdziakra, V., Schick, R., De La Fuente, A., Holland, A., Brantl, V. & Pfeiffer, E. F. 1983 b Effect of β-casomorphins on somatostatin release in dogs. Endocrinology 112 1948–1951CrossRefGoogle Scholar